# Intralipid Therapy for Women 35-40 Years With Positive Natural Killer Cells Undergoing Intracytoplasmic Sperm Injection (ICSI)

> **NCT01916798** · PHASE3 · TERMINATED · sponsor: **Cairo University** · enrollment: 200 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Intralipid infusion

## Key facts

- **NCT ID:** NCT01916798
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2015-01
- **Final completion:** 2015-02
- **Target enrollment:** 200 (ACTUAL)
- **Why stopped:** Not able to recruit the number required and due to financial difficulty to pay for intralipids
- **Last updated:** 2020-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01916798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01916798, "Intralipid Therapy for Women 35-40 Years With Positive Natural Killer Cells Undergoing Intracytoplasmic Sperm Injection (ICSI)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01916798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*